Common Stock	3 Months Ended
Mar. 31, 2019
Common Stock
Common Stock	Note 13 Common Stock The Company had 30,958,581 and 30,769,063 shares of Class A common stock outstanding at March 31, 2019 and December 31, 2018, respectively, exclusive of issued non-vested restricted shares. Additionally, the Company had 107,786 and 146,494 shares outstanding at March 31, 2019 and December 31, 2018, respectively, of restricted Class A common stock issued but not yet vested under the 2014 Omnibus Incentive Plan that are not included in shares outstanding until such time that they are vested; however, these shares do have voting and certain dividend rights during the vesting period. On August 5, 2016, the Board of Directors authorized a new share repurchase program for up to $50.0 million from time to time in either the open market or through privately negotiated transactions. The remaining authorization under this program as of March 31, 2019 was $12.6 million.

Common Stock

3 Months Ended

Mar. 31, 2019

Note 13 Common Stock

The Company had 30,958,581 and 30,769,063 shares of Class A common stock outstanding at March 31, 2019 and December 31, 2018, respectively, exclusive of issued non-vested restricted shares. Additionally, the Company had 107,786 and 146,494 shares outstanding at March 31, 2019 and December 31, 2018, respectively, of restricted Class A common stock issued but not yet vested under the 2014 Omnibus Incentive Plan that are not included in shares outstanding until such time that they are vested; however, these shares do have voting and certain dividend rights during the vesting period.

On August 5, 2016, the Board of Directors authorized a new share repurchase program for up to $50.0 million from time to time in either the open market or through privately negotiated transactions. The remaining authorization under this program as of March 31, 2019 was $12.6 million.